Type 2 Diabetes

A telemedicine-based nutrition counselling program emphasizing a low-carbohydrate diet resulted in sustained diabetes remission over half a decade for some individuals with type 2 diabetes, results of an open-label study showed.

Children with obesity have increased risk for type 2 diabetes if they are diagnosed with metabolic dysfunction-associated steatotic liver disease, according to findings published in Diabetes Care.

SAN DIEGO — Glucagon-like peptide-1 receptor agonists may help alleviate risk for adverse liver outcomes, particularly hepatic decompensation, among patients with type 2 diabetes and alcohol-associated liver disease.

CHICAGO — An intensive blood pressure strategy resulted in a lower incidence of major cardiovascular events compared with a more standard strategy among patients with type 2 diabetes and elevated systolic blood pressure in the BPROAD trial.

Low income corresponded with a higher risk for death among individuals with type 2 diabetes, a South Korean-based cohort analysis published in JAMA Network Open suggested.

SAN DIEGO — Semaglutide was associated with lower risk for major kidney complications for adults with type 2 diabetes and chronic kidney disease without regard to baseline kidney function, data show.

SAN ANTONIO — Dysregulated amino and fatty acid metabolism during late pregnancy was tied to elevated incidence of type 2 diabetes among women with a history of gestational diabetes, according to a presentation at ObesityWeek.

A decade after receiving gastric bypass or sleeve gastrectomy as adolescents, many people maintain their weight loss and achieve remission of obesity-related conditions, including diabetes, according to a study.

ORLANDO — A pilot study found a hybrid online/in-person version of the Complete Health Improvement Program could be feasible for patients with type 2 diabetes, according to a poster presented at the Lifestyle Medicine Conference.

PHILADELPHIA — Patients with type 2 diabetes on glucagon-like peptide-1 receptor agonists had significantly lower risk for pancreatic cancer compared with those on other antidiabetic therapies, regardless of weight, according to data.